Seeking Alpha

  Urologix, Inc. (ULGX) - OTCQB

  • Jim Van Meerten | Send Message 9 Nov 2011

    ULGX - Sell - 60% Barchart short term sell signal - 28.68% below its 1 year high - Relative strength Index 45.64% and falling
      ULGX vs. ETF Alternatives
      Company Description
      Urologix, Inc. develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from non-cancerous prostate enlargement also known as benign prostatic hyperplasia (BPH).